Genome-wide association study in minority children with asthma implicates DNAH5 in bronchodilator responsiveness
- PMID: 35869121
- PMCID: PMC9307508
- DOI: 10.1038/s41598-022-16488-6
Genome-wide association study in minority children with asthma implicates DNAH5 in bronchodilator responsiveness
Abstract
Variability in response to short-acting β2-agonists (e.g., albuterol) among patients with asthma from diverse racial/ethnic groups may contribute to asthma disparities. We sought to identify genetic variants associated with bronchodilator response (BDR) to identify potential mechanisms of drug response and risk factors for worse asthma outcomes. Genome-wide association studies of bronchodilator response (BDR) were performed using TOPMed Whole Genome Sequencing data of the Asthma Translational Genomic Collaboration (ATGC), which corresponded to 1136 Puerto Rican, 656 Mexican and 4337 African American patients with asthma. With the population-specific GWAS results, a trans-ethnic meta-analysis was performed to identify BDR-associated variants shared across the three populations. Replication analysis was carried out in three pediatric asthma cohorts, including CAMP (Childhood Asthma Management Program; n = 560), GACRS (Genetics of Asthma in Costa Rica Study; n = 967) and HPR (Hartford-Puerto Rico; n = 417). A genome-wide significant locus (rs35661809; P = 3.61 × 10-8) in LINC02220, a non-coding RNA gene, was identified in Puerto Ricans. While this region was devoid of protein-coding genes, capture Hi-C data showed a distal interaction with the promoter of the DNAH5 gene in lung tissue. In replication analysis, the GACRS cohort yielded a nominal association (1-tailed P < 0.05). No genetic variant was associated with BDR at the genome-wide significant threshold in Mexicans and African Americans. Our findings help inform genetic underpinnings of BDR for understudied minority patients with asthma, but the limited availability of genetic data for racial/ethnic minority children with asthma remains a paramount challenge.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2020 Update) [Internet] (2020). https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-...
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201600032C/ES/NIEHS NIH HHS/United States
- R01 HL141992/HL/NHLBI NIH HHS/United States
- UM1 HG008901/HG/NHGRI NIH HHS/United States
- R01 DK113003/DK/NIDDK NIH HHS/United States
- P60 MD006902/MD/NIMHD NIH HHS/United States
- R01 HL117004/HL/NHLBI NIH HHS/United States
- R01 HL117626/HL/NHLBI NIH HHS/United States
- U24 HG008956/HG/NHGRI NIH HHS/United States
- R01 HL128439/HL/NHLBI NIH HHS/United States
- R01 HL120393/HL/NHLBI NIH HHS/United States
- R01 AI079139/AI/NIAID NIH HHS/United States
- U01 HL120393/HL/NHLBI NIH HHS/United States
- R01 HL118267/HL/NHLBI NIH HHS/United States
- U01 HG009080/HG/NHGRI NIH HHS/United States
- R01 HL135156/HL/NHLBI NIH HHS/United States
- R01 HL133433/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- P30 ES013508/ES/NIEHS NIH HHS/United States
- R01 HL079966/HL/NHLBI NIH HHS/United States
- R01 MD010443/MD/NIMHD NIH HHS/United States
- P01 HL132825/HL/NHLBI NIH HHS/United States
- R01 ES015794/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
